Halda Therapeutics has 6 close competitors: Atomwise, Ecovativa Design, NantOmics.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
AtomwiseEcovativa DesignNantOmicsInsitroFormation BioHalda Therapeutics develops therapeutic solutions.
Halda Therapeutics competes with 6 companies here: Atomwise, Ecovativa Design, NantOmics, Insitro, Formation Bio, Retro Biosciences.
Halda Therapeutics was last valued at $250M . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Halda Therapeutics is a private company; its shares do not trade on a public exchange.
The last valuation is $250M.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
